🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial compares the effect of hypofractionated radiotherapy (H...
Status
Recruiting
Location
Uganda Cancer Institute
Start Date
2026-03-11
Trial ID
NCT07276360
External radiation given in 25 fractions or so together with weekly chemoth...
Status
Active Not Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-09-19
Trial ID
NCT05994300
Treatments Being Tested
This is a prospective, interventional pilot study to evaluate the feasibili...
Status
Unknown
Location
Pontificia Universidad Catolica de Chile
Start Date
2021-06-22
Trial ID
NCT05123391
Treatments Being Tested
This is a single-arm phase II prospective trials that is recruiting 100 par...
Status
Recruiting
Location
Princess Margaret Cancer Center
Start Date
2022-07-18
Trial ID
NCT05313815
Treatments Being Tested
Cancer of the uterine cervix is one of the most common gynecologic cancer d...
Status
Recruiting
Location
Ainshams University
Start Date
2025-07-01
Trial ID
NCT07343531
Treatments Being Tested
We will investigate whether ultrahypofractionation using stereotactic ablat...
Status
Recruiting
Location
British Columbia Cancer Agency Center for the Southern Interior
Start Date
2021-07-12
Trial ID
NCT04610372
This is an ambispective, multicenter, observational real-world registry of ...
Status
Recruiting
Location
Affidea Nu-med Center of Oncological Diagnostics and Therapy
Start Date
2026-06-26
Trial ID
NCT07686016
This phase II trial studies the side effects of radiation therapy \[hypofra...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Start Date
2020-01-06
Trial ID
NCT04190446
This is a multi-institution, randomized, non-inferiority Phase II trial com...
Status
Recruiting
Location
London Health Sciences Centre
Start Date
2024-11-26
Trial ID
NCT06409910
Treatments Being Tested